Article Text

Download PDFPDF
Response to: ‘Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis’ by Wu et al
  1. Elien A M Mahler1,
  2. Michiel J M Minten1,
  3. Mathilde M Leseman-Hoogenboom2,
  4. Philip M P Poortmans2,3,
  5. Jan Willem H Leer2,
  6. Simone S Boks4,
  7. Frank H J van den Hoogen5,
  8. Alfons A den Broeder1,
  9. Cornelia HM van den Ende1
  1. 1 Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands
  2. 2 Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
  3. 3 Department of Radiation Oncology, Institut Curie, Paris, France
  4. 4 Department of Radiology, Sint Maartenskliniek, Nijmegen, The Netherlands
  5. 5 Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands
  1. Correspondence to Elien A M Mahler, Department of Rheumatology, Sint Maartenskliniek, Nijmegen 6500 GM, The Netherlands; e.mahler{at}maartenskliniek.nl

Statistics from Altmetric.com

We thank Wu et al for their interest in and encouragement of our randomised studies in which we found no substantial beneficial effect on symptoms and inflammatory signs of low-dose radiation therapy (LDRT) in patients with knee and hand osteoarthritis (OA).1–3 The authors emphasise that our results inevitably force involved clinicians to re-examine the true effectiveness of LDRT on OA in real-world clinical practice. However, they addressed two constructive concerns related to our work, to which we will reply hereby.

The first point addresses the heterogeneity of the participants reflecting a real-world population, that is, patients with clinical diagnosis of knee OA after failure of conservative treatment options. Wu et al suggest that randomisation stratified by an objective measure for severity of knee OA (eg, K&L scores) might be preferable to the numeric rating scale for pain to stratify patients. We do not agree on this point because we hypothesised that LDRT would primarily improve clinically relevant OA symptoms including pain and disfunctioning. Accordingly, the …

View Full Text

Footnotes

  • Handling editor Josef S Smolen

  • Contributors The authors declare the following contributions to the preparation of the response: drafting of the manuscript (EAMM, MLMM, CHvdE); critical revision of the manuscript for important intellectual content (all authors); final approval of the manuscript (all authors). All authors take responsibility for the integrity of the work and agreed to submit the response for publication.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles